Clinical Trial Update: A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB) [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study evaluating Aricept in patients with dementia with Lewy bodies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia Lewy Body
• Lewy Body Disease

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Dementia, Lewy Body, Lewy Body Disease | Phase 4 | Status: COMPLETED